Quadrant Capital Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-189
Closed -$1.16K 2775
2025
Q4
$1.16K Hold
189
﹤0.01% 2582
2025
Q3
$1.37K Buy
+189
New +$1.12K ﹤0.01% 2527
2025
Q2
Sell
-15,246
Closed -$135K 2126
2025
Q1
$135K Buy
15,246
+15,065
+8,323% +$181K 0.01% 1448
2024
Q4
$2.48K Sell
181
-461
-72% -$8.51K ﹤0.01% 2468
2024
Q3
$17.6K Sell
642
-15
-2% -$406 ﹤0.01% 1950
2024
Q2
$16.1K Sell
657
-203
-24% -$4.45K ﹤0.01% 1947
2024
Q1
$18.3K Buy
860
+189
+28% +$4.06K ﹤0.01% 1884
2023
Q4
$12.8K Buy
671
+523
+353% +$9.05K ﹤0.01% 1981
2023
Q3
$2.37K Sell
148
-145
-49% -$2.76K ﹤0.01% 2348
2023
Q2
$6.79K Buy
293
+65
+29% +$1.42K ﹤0.01% 2130
2023
Q1
$5.3K Sell
228
-343
-60% -$6.97K ﹤0.01% 2218
2022
Q4
$8.29K Buy
571
+384
+205% +$7.16K ﹤0.01% 2045
2022
Q3
$4K Hold
187
﹤0.01% 2216
2022
Q2
$3K Buy
187
+94
+101% +$1.95K ﹤0.01% 2124
2022
Q1
$2K Hold
93
﹤0.01% 2167
2021
Q4
$3K Hold
93
﹤0.01% 2043
2021
Q3
$3K Buy
+93
New +$3.09K ﹤0.01% 2039
2020
Q3
Sell
-2,824
Closed -$32K 2252
2020
Q2
$32K Buy
+2,824
New +$40.1K 0.01% 886
2020
Q1
Sell
-1,052
Closed -$28K 2208
2019
Q4
$28K Hold
1,052
﹤0.01% 1596
2019
Q3
$29K Hold
1,052
﹤0.01% 1458
2019
Q2
$28K Buy
1,052
+956
+996% +$27K ﹤0.01% 1494
2019
Q1
$2K Buy
96
+41
+75% +$1.25K ﹤0.01% 2070
2018
Q4
$1K Hold
55
﹤0.01% 2068
2018
Q3
$2K Hold
55
﹤0.01% 1881
2018
Q2
$2K Hold
55
﹤0.01% 1887
2018
Q1
$1K Hold
55
﹤0.01% 2025
2017
Q4
$1K Hold
55
﹤0.01% 1974
2017
Q3
$1K Hold
55
﹤0.01% 1988
2017
Q2
$0 Hold
55
﹤0.01% 1987
2017
Q1
$1K Buy
+55
New +$975 ﹤0.01% 1839
2016
Q2
Sell
-151
Closed -$5K 2040
2016
Q1
$5K Buy
+151
New +$5.69K ﹤0.01% 1167

Other funds holding MYGN